Start A Thread

Rate Bioventus

  • Culture

  • Compensation

  • Opportunity for advancement

  • Realistic plan attainment

×

Salaries

In our drive to help people in the medical sales industry we are gathering salary data. This information will be collated, analyzed and number crunched. Medtechy’s overall goal is to help the medical sales industry make more informed decisions when changing jobs and also keep employers and recruiters honest

Take 30 seconds and let us know your current deal.*

About The Position

Compensation

* We guarantee all data collected is completely anonymous and will only be used for the benefit of future visitors.

×

Hot Ticker Articles

What's Next for TransEnterix after Senhance's FDA Clearance

Business Travel Tip: Watch your home TV with a streaming stick

Depuy Attune objection handling presentation and the new Attune S+ technology

Apple one of 9 companies chosen for FDA pilot program and what it means for the revolution in digital healthcare

Titan Medical Announces First Procedures with SPORT Surgical System

Highlights from Nevro's Presentation at the Morgan Stanley 2017 Global Healthcare Conference

TransEnterix is one step closer to FDA approval for Senhance

Did Medtronic accidentally release the name of their robotic surgery program?

Can TransEnterix overtake Intuitive Surgical in the robotic surgery race?

Boost sales with a simple 7 step pre-call plan

4 Tips for Managing a New Medical Sales Territory

Job Listings

RIP Exogen, Part Deux

1 week ago

Coverage reductions and management decisions are bringing this glorious product to a slow death.

Goodbye my special friend. Good bye.

Bioventus News

3 weeks ago

Bioventus Announces First Patients Enrolled in BONES Study for EXOGEN

Durham, NC- September 13, 2017 - Bioventus, a global leader in orthobiologics, today announced the first patients have been enrolled in its BONES (Bioventus Observational Non-interventional EXOGEN Studies) clinical development program. BONES includes three observational, non-interventional, direct-to-patient studies designed to collect real world data on the use of the EXOGEN Ultrasound Bone Healing System. EXOGEN uses safe, e…

Bioventus Announces First Patients Enrolled in BONES Study for EXOGEN®

Bioventus Announces First Patients Enrolled in BONES Study for EXOGEN® Durham, NC– September 13, 2017 – Bioventus, a global leader in orthobiologics, today announced the first patients have been enrolled in its BONES (Bioventus Observational Non-interventional EXOGEN Studies) clinical development program. BONES includes three observational, non-interventional, direct-to-patient studies designed to collect real world data on the use of

Bioventus Delays IPO

1 year ago

Bioventus Delays IPO

Bioventus, a global leader in orthobiologics, postponed their IPO on Friday.The Durham, NC based company filed for their initial public offering in early July hoping to raise $150 million by offering 8.8 million shares at a price range of $16 to $18.

ES Reps, 2015 and Beyond

3 years ago

Yes. Everyone is going to go work for DJ Ortho and BV will crumble.

Bioventus and Stryker

3 years ago

You do realize that we would be out of a job after Stryker absorbs all of our products? I don't love my job but I like having a job. More importantly, having to let all of us go would make way too much paperwork for Leigh Ann so she would without question give the deal a thumbs down.

Bioventus is Now a Stepping Stone

3 years ago

I feel like we're always hiring due to so many departures. I noticed a bunch of positions posted online for reps.

Loading...